基于网络药理学和分子对接探讨补肺健脾方治疗慢性阻塞性肺疾病的作用机制OA
Exploring the Mechanism of Action of Lung-Supplementing and Spleen-Invigorating Decoction in the Treatment of Chronic Obstructive Pulmonary Disease Based on Network Pharmacology and Molecular Docking
目的:基于网络药理学和分子对接探讨补肺健脾方治疗慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)的作用机制.方法:通过中药系统药理学数据库与分析平台(traditional Chinese medicine systems pharmacology database and a-nalysis platform,TCMSP)搜索补肺健脾方组方中药活性成分.采用 Swiss Target Prediction 数据库获取活性成分的作用靶点.在 GeneCards 数据库中搜索 COPD 相关靶标.使用 Venny 2.1.0 确定补肺健脾方和 COPD 的共同靶点.将共同靶点导入STRING 数据库分析蛋白质相互作用关系,采用 Cytoscape 3.9.0 进行蛋白质-蛋白质相互作用(protein-protein interaction,PPI)网络可视化,拓扑分析筛选核心靶点.将核心靶点导入 DAVID 数据库进行基因本体论(Gene Ontology,GO)富集分析和京都基因与基因组百科全书(Kyoto Encyclopedia of Genes and Genomes,KEGG)信号通路富集分析.利用 AutoDockTools 1.5.6对核心靶点和关键成分进行分子对接.结果:在 TCMSP 数据库中获得补肺健脾方活性成分 71 个,相关靶基因 727 个.在GeneCards 数据库中检索得到2 645 个靶基因.将活性成分相关靶点与疾病靶点导入 Venny 2.1.0 在线软件,绘制 Venny 图,获得共同靶点328 个.将共同靶点导入 STRING 构建 PPI 网络,拓扑分析得到白细胞介素-6(interleukin-6,IL-6)、蛋白激酶 B1(protein kinase B1,PKB1,又称 AKT1)等33 个核心靶点.GO 富集分析得到111 个分子功能、44 个细胞组分、382 个生物学过程.KEGG 富集分析得到144 条信号通路.分子对接显示:核心靶点与成分对接良好.结论:补肺健脾方通过多靶点、多成分与多通路治疗 COPD,为补肺健脾方治疗 COPD 提供理论依据.
Objective:To explore the mechanism of action of Lung-Supplementing and Spleen-Invigorating Decoction in the treatment of chronic obstructive pulmonary disease(COPD)based on network pharmacology and molecular docking.Methods:The active compo-nents of Chinese medicinals in Lung-Supplementing and Spleen-Invigorating Decoction were searched through the traditional Chinese medicine systems pharmacology database and analysis platform(TCMSP).The Swiss Target Prediction database was used to obtain the targets of the active components.COPD-related targets were searched in the GeneCards database.Venny 2.1.0 was used to identify the common targets between Lung-Supplementing and Spleen-Invigorating Decoction and COPD.The common targets were imported into the STRING database for protein-protein interaction(PPI)analysis,and Cytoscape3.9.0 was used for PPI network visualization and topol-ogical analysis to screen core targets.The core targets were imported into the DAVID database for Gene Ontology(GO)enrichment and Kyoto Encyclopedia of Genes and Genomes(KEGG)signaling pathway enrichment analyses.Molecular docking of core targets and key components was performed using AutoDockTools 1.5.6.Results:A total of 523 active components and 727 related target genes of Lung-Supplementing and Spleen-Invigorating Decoction were obtained from the TCMSP database.A total of 2,645 target genes were retrieved from the GeneCards database.The component-related targets and disease targets were imported into Venny 2.1.0 online software to gen-erate a Venn diagram,yielding 328 common targets.The common targets were imported into STRING to construct a PPI network.Topolo-gical analysis identified 33 core targets,including interleukin-6(IL-6),protein kinase B1(PKB1,also known as AKT1),etc.GO en-richment analysis yielded 111 molecular functions,44 cellular components,and 382 biological processes.KEGG enrichment analysis i-dentified 144 signaling pathways.Molecular docking showed that the core targets bound well with the components.Conclusion:Lung-Supplementing and Spleen-Invigorating Decoction treats COPD through multi-component,multi-target and multi-pathway mechanisms,laying a theoretical basis for its application in COPD therapy.
余晓珂;任平
河南中医药大学第三附属医院,河南 郑州 450008河南中医药大学,河南 郑州 450046
医药卫生
慢性阻塞性肺疾病补肺健脾方网络药理学分子对接
chronic obstructive pulmonary disease(COPD)Lung-Supplementing and Spleen-Invigorating Decoctionnetwork pharma-cologymolecular docking
《河南中医》 2026 (6)
883-889,7
河南省中医药科学研究专项课题项目(2018ZY1018)
评论